Endologix, Inc. Completes $40 Million Public Offering of Common Stock

Represented medical device innovator Endologix, Inc. (Nasdaq:ELGX) in its $40 million registered public offering of common stock. Piper Jaffray acted as sole underwriter.

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA).